Management

Zoya Cheglakov, Ph.D.
CEO, President & cofounder

Zoya completed her postdoctoral research at the University of Chicago, where she co-invented Sensona’s nanoparticle synthesis and IR-PCR technology. She has 17 years of experience in DNA nanotechnology, developing innovative techniques for academic research and clinical applications. Expert in nucleic acid amplification methods, including ultra-sensitive DNA nanomachines for ultrafast diagnostics of infectious diseases. Author of 17 scientific papers, coordinator of international grants, co-inventor of 3 patents/patent applications

B.S., M.S. The Hebrew University of Jerusalem (Chemistry), Ph.D. The University of Chicago (Chemistry)

Yossi Weizmann, Ph.D.
Chairman Scientific Advisory Council & cofounder

Yossi Weizmann's, Professor of Chemistry, expertise sits at the cutting edge of the chemistry, biology, and materials science fields with various interdisciplinary approaches, including bioelectronics, bionanotechnology, surface chemistry, and novel nanomaterials. He has 22 years' extensive background in nucleic acid amplification methods and in designing bioelectronic sensors with wide experience in the development of ultrasensitive bio-electronic and optical detection schemes for nucleic acids and proteins. Professor Weizmann has 60 peer-reviewed publications, seven patents, and leads the research team behind Sensona’s photothermic thermocycling method

Ph.D. The Hebrew University of Jerusalem (Chemistry), Post-doctorate MIT

Board of Directors

Dr. Zoya Cheglakov

CEO, President & cofounder

Dr. Yossi Weizmann

Chairman Scientific Advisory Council & cofounder

Michael O'Malley

Business & Financial Advisor

Board of Advisors

Nimrod B. Weizmann, MD
Medical Director

Nimrod Weizmann, MD, is an expert in OB/GYN, Infertility, and STDs with extensive experience in the diagnosis and treatment of sexually transmitted diseases. Nimrod is the head of the Emergency Obstetrics and Gynecology Department and ER. He is a primary care doctor, and an attending physician Ob/GYN at Laniado Hospital, Netanya. Dr. Weizmann’s outstanding skills, problem-solving ability, and network of professional contacts in the medical and gynecologic fields help Sensona to identify areas for further development and to complete its goals with maximum productivity

Amir Lichtenstein, Ph.D. 

Consultant, Technological  Advisor 

Dr. Lichtenstein brings to Sensona decades of fruitful and successful experience in turning innovative ideas into products.  He was the PD of RAM GROUP Global, the CTO of GreinDX AS,  Traceense  LTD,  Physical Logic AG, and Sienna Cancer Diagnostics (Sensogene). He is the co-founder of NAALOS AS,  GreinDX AS & Tracense LTD.  He has authored 29 patents and a number of peer-reviewed articles, among them Nature biotechnology and Nature communications

Michael O'Malley
Business & Financial Advisor


Michael has over 40 years of experience in financing, negotiating, and marketing management. His knowledge and skills to work with providers and to manage the sales force play a crucial role in Sensona's projects. Michael primary focus in Sensona is on forecasting business opportunities, hiring, and training personnel
 

M.A. Loyola University, OPM Harvard Business School